'Switch patients from osteoarthritis painkiller'

GPs must stop prescribing the painkiller lumiracoxib (Prexige) and switch patients to an alternative drug, says the Medicines and Healthcare products Regulatory Agency (MHRA).

Concerns over liver damage caused by the cyclooxygenase (COX)-2 inhibitor has led to suspension of the drug’s UK licence by the MHRA.

It follows similar moves by Australia, New Zealand, Turkey, the US and Canada earlier this year.

Data has shown that an increase in the number of serious liver reactions that have occurred with the licensed 100mg dose, some of which occurred within one month of use.

The drug was licensed for pain relief in osteoarthritis of the knee and hip and has been available in the UK since December 2005.

Between October 2006 and September 2007 alone, around 5,000 UK patients were given one or more scrips for the drug.

Up to 13 November, the MHRA received 23 reports of severe adverse reactions, three of which were liver reactions.

In August, the MHRA said the drug must be contraindicated in patients with a history of liver problems. But after closer examination of the evidence, the Committee on the Safety of Human Medicines, which is part of the MHRA, ruled that ‘previous measures could not be relied upon to guarantee patient safety’.

The latest finding adds to concerns about the side effects of COX-2 inhibitors after research linked them to an increased risk of cardiovascular event.

A spokeswoman for manufacturer Novartis advised GPs to make appointments for patients as soon as convenient to discuss switching to an alternative treatment.

‘Novartis continues to believe Prexige is an important treatment option,’ she added.

rachel.liddle@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK hits 1m second doses of COVID-19 vaccine as campaign shifts to next phase

UK hits 1m second doses of COVID-19 vaccine as campaign shifts to next phase

More than 1m people UK-wide have now had two doses of COVID-19 vaccine, official...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

What GPs need to know about the GMC's new guidance on prescribing

What GPs need to know about the GMC's new guidance on prescribing

MDU medico-legal adviser Kathryn Leask explains the key issues GPs need to be aware...

PCNs promised missing COVID-19 vaccine pay this month after cashflow warning

PCNs promised missing COVID-19 vaccine pay this month after cashflow warning

NHS England has promised to deliver thousands of pounds in missing payments to GP...

Chancellor's 'unfair tax on doctors' could drive 72% into early retirement, BMA warns

Chancellor's 'unfair tax on doctors' could drive 72% into early retirement, BMA warns

A five-year freeze on the pensions lifetime allowance in the government's 2021 budget...

Doctors warn of 'massive impact' on workforce as Sunak freezes pension lifetime allowance

Doctors warn of 'massive impact' on workforce as Sunak freezes pension lifetime allowance

Chancellor Rishi Sunak has confirmed a five-year freeze on the pension lifetime allowance...